References
- FDA U.S. Food and Drug Administration (FDA). Patient-reported outcome measures: use in medical product development to support labeling claims. 2006. Rockville: Food and Drug Administration. www.fda.gov/cber/gdlns/problbl.html.
- Basch E, Wilfong L, Schrag D. Adding patient-reported outcomes to medicaredical product development to supmodel. Jama. 2020;323(3):213–214. doi:https://doi.org/10.1001/jama.2019.19970
- Basch E, Barbera L, Kerrigan CL, Velikova G. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;38:122–134. doi:https://doi.org/10.1200/EDBK_200383
- Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Jama. 2017;318(2):197–198. doi:https://doi.org/10.1001/jama.2017.7156
- Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol . 2016;34(6):557–565. doi:https://doi.org/10.1200/JCO.2015.63.0830
- Bottomley A, Reijneveld JC, Koller M, et al. Current state of quality of life and patient-reported outcomes research. Eur J Cancer. 2019;121:55–63. doi:https://doi.org/10.1016/j.ejca.2019.08.016
- Coens C, Pe M, Dueck AC, et al. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Lancet Oncol. 2020;21(2):e83–e96. doi:https://doi.org/10.1016/S1470-2045(19)30790-9
- Lugtenberg RT, Fischer MJ, de Jongh F, et al. Using a Quality of Life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancer. Qual Life Res. 2020;29(11):2961–2975. doi:https://doi.org/10.1007/s11136-020-02549-8
- Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med. 2005;60(4):833–843. doi:https://doi.org/10.1016/j.socscimed.2004.06.022
- Ambroggi M, Biasini C, Toscani I, et al. Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature. Support Care Cancer. 2018;26(9):2945–2953. doi:https://doi.org/10.1007/s00520-018-4184-3
- Mierzynska J, Piccinin C, Pe M, et al. Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review. Lancet Oncol. 2019;20(12):e685–e698. doi:https://doi.org/10.1016/S1470-2045(19)30656-4
- Sullivan DR, Forsberg CW, Ganzini L, et al. Longitudinal changes in depression symptoms and survival among patients with lung cancer: a national cohort assessment. J Clin Oncol. 2016;34(33):3984–3991. doi:https://doi.org/10.1200/JCO.2016.66.8459
- Temel JS, Greer JA, El-Jawahri A, et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol. 2017;35(8):834–841. doi:https://doi.org/10.1200/JCO.2016.70.5046
- Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–742. doi:https://doi.org/10.1056/NEJMoa1000678
- Haslam A, Herrera FromOnliD, Gill J, Prasad V. Patient experience captured by quality-of-life measurement in oncology clinical trials. JAMA Netw Open. 2020;3(3):e200363–19. doi:https://doi.org/10.1001/jamanetworkopen.2020.0363
- Dein S. Explanatory models of and attitudes towards cancer in different cultures. Lancet Oncol. 2004;5(2):119–124. doi:https://doi.org/10.1016/S1470-2045(04)01386-5
- Kleinman A, Eisenberg L, Good B. Culture, illness, and care. Ann Intern Med. 1978;88(2):251–258. doi:https://doi.org/10.7326/0003-4819-88-2-251
- Okuyama T, Endo C, Seto T, et al. Cancer patients' reluctance to disclose their emotional distress to their physicians: a study of Japanese patients with lung cancer. Psychooncology. 2008;17(5):460–465. doi:https://doi.org/10.1002/pon.1255
- Ashing-Giwa KT, Padilla G, Tejero J, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology. 2004;13(6):408–428. doi:https://doi.org/10.1002/pon.750
- Ishikawa H, Takayama T, Yamazaki Y, Seki Y, Katsumata N, Aoki Y. The interaction between physician and patient communication behaviors in Japanese cancer consultations and the influence of personal and consultation characteristics. Patient Educ Couns. 2002;46(4):277–285. doi:https://doi.org/10.1016/S0738-3991(01)00164-1
- Aelbrecht K, Hanssens L, Detollenaere J, Willems S, Deveugele M, Pype P. Determinants of physician-patient communication: the role of language, education and ethnicity. Patient Educ Couns. 2019;102(4):776–781. doi:https://doi.org/10.1016/j.pec.2018.11.006
- Kleijn WC, Ogoshi K, Yamaoka K, et al. Conceptual equivalence and health-related quality of life: an exploratory study in Japanese and Dutch cancer patients. Qual Life Res. 2006;15(6):1091–1101. doi:https://doi.org/10.1007/s11136-006-0049-1
- Fischer MJ, Krol er FromOnlinEMM, Ranke GMC, et al. Routine monitoring of quality of life for patients with breast cancer: an acceptability and field test. J Psychosoc Oncol. 2012;30(2):239–259. doi:https://doi.org/10.1080/07347332.2011.644398
- Fischer MJ, Inoue K, Matsuda A, et al. Cross-cultural comparison of breast cancer patients.644398" er: ancer: ry study in Japanese and D. Breast Cancer Res Treat. 2017;166(2):459–471. doi:https://doi.org/10.1007/s10549-017-4417-z
- Kaptein AA, Yamaoka K, Snoei L, et al. Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer. Lung Cancer. 2011;72(3):384–390. doi:https://doi.org/10.1016/j.lungcan.2010.09.010
- Kaptein AA, Yamaoka K, Snoei L, et al. Illness perceptions and quality of life in Japanese and Dutch women with breast cancer. J Psychosoc Oncol. 2013;31(1):83–102. doi:https://doi.org/10.1080/07347332.2012.741092
- Kobayashi K, Green J, Shimonagayoshi M, et al. Validation of the care notebook for measuring physical, mental and life well-being of patients with cancer. Qual Life Res. 2005;14(4):1035–1043. doi:https://doi.org/10.1007/s11136-004-2958-1
- Matsuda A, Yamada Y, Ishizuka N, et al. Effectiveness of a self-monitoring quality of life intervention for patients with cancer receiving palliative care: a randomized controlled clinical trial. Asian Pac J Cancer Prev. 2019;20(9):2795–2802. doi:https://doi.org/10.31557/APJCP.2019.20.9.2795
- Young J, Badgery-Parker T, Dobbins T, Jorgensen M, Gibbs P, Faragher I, Jones I, Currow D. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status. J Pain Symptom Manage. 2015;49(2):258–64.
- Hilarius DL, Kloeg PH, Gundy CM, Aaronson NK. Use of health-related quality-of-life assessments in daily clinical oncology nursing practice. Cancer. 2008;113(3):628–637. doi:https://doi.org/10.1002/cncr.23623
- van der Kloot WA, Uchida Y, Inoue K, et al. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer. Chin Clin Oncol. 2016;5:3.
- Matsui T, Hirai K, Shokoji M, et al. Problems, goals and solutions reported by cancer patients participating in group problem-solving therapy. Jpn J Clin Oncol. 2019;49(3):245–256. doi:https://doi.org/10.1093/jjco/hyy191
- Sakai H, Umeda M, Okuyama H, Nakamura S. Differences in perception of breast cancer treatment between patients, physicians, and nurses and unmet information needs in Japan. Support Care Cancer. 2020;28(5):2331–2338.
- Kasahara - Kiritani M, Matoba T, Kikuzawa S, et al. Public perceptions toward mental illness in Japan. Asian J Psychiatr. 2018;35:55–60. doi:https://doi.org/10.1016/j.ajp.2018.05.021
- Uchida M, Sugie C, Yoshimura M, et al. Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy. Support Care Cancer. 2019;27(12):4487–4495. doi:https://doi.org/10.1007/s00520-019-04716-1
- Fujimori M, Shirai Y, Asai M, Kubota K, Katsumata N, Uchitomi Y. Effect of communication skills training program for oncologists based on patient preferences for communication when receiving bad news: a randomized controlled trial. J Clin Oncol. 2014;32(20):2166–2172. doi:https://doi.org/10.1200/JCO.2013.51.2756
- Sasaki H, Tamura K, Naito Y, et al. Patient perceptions of symptoms and concerns during cancer chemotherapy: 'affects my family' is the most important. Int J Clin Oncol. 2017;22(4):793–800. doi:https://doi.org/10.1007/s10147-017-1117-y
- Atema V, van Leeuwen M, Kieffer JM, et al. Efficacy of internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial. J Clin Oncol. 2019;37(10):809–822. doi:https://doi.org/10.1200/JCO.18.00655
- Compen F, Bisseling E, Schellekens M, et al. Face-to-face and internet-based mindfulness-based cognitive therapy compared with treatment as usual in reducing psychological distress in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol. 2018;36(23):2413–2421. doi:https://doi.org/10.1200/JCO.2017.76.5669
- Farthmann J, Hanjalic omOnliA, Veit J, et al. The impact of chemotherapy for breast cancer on sexual function and health-related quality of life. Support Care Cancer. 2016;24(6):2603–2609. doi:https://doi.org/10.1007/s00520-015-3073-2
- Kaptein AA, Schoones JW, Fischer MJ, Thong MSY, Kroep JR, van der Hoeven KJM. Illness perceptions in women with breast cancer -3073-2" nction and health-relat. Curr Breast Cancer Rep. 2015;7(3):117–126. doi:https://doi.org/10.1007/s12609-015-0187-y
- Jabbarian LJ, Rietjens JAC, Mols F, Oude Groeniger J, Heide A, Korfage IJ. Untangling the relationship between negative illness perceptions and worse quality of life in patients with advanced cancer lth-relath treatment as usual in reducing psychologic. Support Care Cancer. 2021. Online ahead of print
- Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647–2655. doi:https://doi.org/10.1200/JCO.2018.79.2721
- Matsuda A, Yamaoka K, Tango T, Matsuda T, Nishimoto H. Effectiveness of psychoeducational support on quality of life in early - stage breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Qual Life Res. 2014;23(1):21–30. doi:https://doi.org/10.1007/s11136-013-0460-3
- Rodin G, An E, Shnall J, Malfitano C. Psychological interventions for patients with advanced disease: implications for oncology and palliative care. J Clin Oncol. 2020;38(9):885–904. doi:https://doi.org/10.1200/JCO.19.00058
- Kaptein AA, Kobayashi K, Matsuda A, et al. We alda i omOnlineneMalfpatients’, caregivers’ and health care providers’ illness perceptions about non-small-cell lung cancer (NSCLC). Lung Cancer. 2015;90(3):575–581. doi:https://doi.org/10.1016/j.lungcan.2015.10.017